The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Role of interleukin 10 in specific immunotherapy.
Open accessAbstract
The induction of allergen-specific anergy in peripheral T cells represents a key step in specific immunotherapy (SIT). Here we demonstrate that the anergic state results from increased IL-10 production. In bee venom (BV)-SIT the specific proliferative and cytokine responses against the main allergen, the phospholipase A2 (PLA), and T cell epitope-containing PLA peptides were significantly suppressed after 7 d of treatment. Simultaneously, the production of IL-10 increased during BV-SIT. After 28 d of BV-SIT the anergic state was established. Intracytoplasmic cytokine staining of PBMC combined with surface marker detection revealed that IL-10 was produced initially by activated CD4(+)CD25(+), allergen-specific T cells, and followed by B cells and monocytes. Neutralization of IL-10 in PBMC fully reconstituted the specific proliferative and cytokine responses. A similar state of IL-10-associated T cell anergy, as induced in BV-SIT, was found in hyperimmune individuals who recently had received multiple bee stings. The addition of IL-10 to soluble CD40 ligand IL-4-stimulated PBMC or purified B cells inhibited the PLA-specific and total IgE and enhanced the IgG4 formation. Accordingly, increased IL-10 production by SIT causes specific anergy in peripheral T cells, and regulates specific IgE and IgG4 production toward normal IgG4-related immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
High gradient magnetic cell separation with MACS
Miltenyi, S., Müller, W., Weichel, W., & Radbruch, A. (1990) · Cytometry · doi:10.1002/cyto.990110203 · Cited by 1,681
Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., de Waal Malefyt, R., & de Vries, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3730 · Cited by 1,102
Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., & Romagnani, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.2.353 · Cited by 927
Aalberse, R. C., van der Gaag, R., & van Leeuwen, J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.722 · Cited by 736
A Controlled Trial of Immunotherapy in Insect Hypersensitivity
Hunt, K. J., Valentine, M. D., Sobotka, A. K., Benton, A. W., Amodio, F. J., & Lichtenstein, L. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197807272990401 · Cited by 710
Del Prete, G., Maggi, E., Parronchi, P., Chrétien, I., Tiri, A., Macchia, D., Ricci, M., Banchereau, J., De Vries, J., & Romagnani, S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4193 · Cited by 707
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.
Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D., & Umetsu, D. T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2123 · Cited by 539
Jutel, M., Pichler, W. J., Skrbic, D., Urwyler, A., Dahinden, C., & Müller, U. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.4187 · Cited by 522
Prussin, C., & Metcalfe, D. D. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00209-x · Cited by 458
Müller, U., Akdis, C. A., Fricker, M., Akdis, M., Blesken, T., Bettens, F., & Blaser, K. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70402-6 · Cited by 456
Self-citationDiagnosis and Treatment of Insect Sensitivity
Mueller, H. L. (1966) · Journal of Asthma Research · doi:10.3109/02770906609106941 · Cited by 420
Bacchetta, R., Bigler, M., Touraine, J. L., Parkman, R., Tovo, P. A., Abrams, J., de Waal Malefyt, R., de Vries, J. E., & Roncarolo, M. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.493 · Cited by 416
Brunner, T., Heusser, C. H., & Dahinden, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.605 · Cited by 380
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
Walker, C., Virchow, J. C., Bruijnzeel, P. L., & Blaser, K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1829 · Cited by 376
Self-citationDing, L., & Shevach, E. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3133 · Cited by 363
Akdis, C. A., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S., Müller, U., & Blaser, K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118963 · Cited by 312
Self-citationInterleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
Zuany-Amorim, C., Hailé, S., Leduc, D., Dumarey, C., Huerre, M., Vargaftig, B. B., & Pretolani, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117966 · Cited by 276
Bellinghausen, I., Metz, G., Enk, A., Christmann, S., Knop, J., & Saloga, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270513 · Cited by 275
Gascan, H., Gauchat, J. F., Aversa, G., Van Vlasselaer, P., & de Vries, J. E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.8 · Cited by 268
Rak, S., Löwhagen, O., & Venge, P. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90021-8 · Cited by 263
Secrist, H., DeKruyff, R. H., & Umetsu, D. T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1081 · Cited by 262
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.
Schandené, L., Alonso-Vega, C., Willems, F., Gérard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M., & Goldman, M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4368 · Cited by 251
Lane, P., Brocker, T., Hubele, S., Padovan, E., Lanzavecchia, A., & McConnell, F. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1209 · Cited by 248
Takanaski, S., Nonaka, R., Xing, Z., O'Byrne, P., Dolovich, J., & Jordana, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.711 · Cited by 237
Induction of hapten-specific tolerance by interleukin 10 in vivo.
Enk, A. H., Saloga, J., Becker, D., Mohamadzadeh, M., & Knop, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1397 · Cited by 224
Hussain, R., Poindexter, R. W., & Ottesen, E. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.9.2731 · Cited by 219
Hsu, D.-H., Moore, K. W., & Splts, H. (1992) · International Immunology · doi:10.1093/intimm/4.5.563 · Cited by 203
Punnonen, J., de Waal Malefyt, R., van Vlasselaer, P., Gauchat, J. F., & de Vries, J. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1280 · Cited by 198
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
Creticos, P. S., Adkinson, N. F., Kagey-Sobotka, A., Proud, D., Meier, H. L., Naclerio, R. M., Lichtenstein, L. M., & Norman, P. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112233 · Cited by 198
Position Paper: Immunotherapy with Hymenoptera venoms
Mailer, U., & Mosbech, H. (1993) · Allergy · doi:10.1111/j.1398-9995.1993.tb04755.x · Cited by 191
Akdis, M., Akdis, C. A., Weigl, L., Disch, R., & Blaser, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.9.4611 · Cited by 190
Self-citationSeasonal asthma in northern California: Allergic causes and efficacy of immunotherapy
Reid, M. J., Moss, R. B., Hsu, Y.-P., Kwasnicki, J. M., Commerford, T. M., & Nelson, B. L. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90076-x · Cited by 185
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity
Furin, M. J., Norman, P. S., Creticos, P. S., Proud, D., Kagey-Sobotka, A., Lichtenstein, L. M., & Naclerio, R. M. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90297-2 · Cited by 165
Marshall, J. S., Leal‐Berumen, I., Nielsen, L., Glibetić, M., & Jordana, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118506 · Cited by 159
T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2
Carballido, J. M., Carballido‐Perrig, N., Kägi, M. K., Meloen, R. H., Wüthrich, B., Heusser, C. H., & Blaser, K. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3582 · Cited by 151
Self-citationSobotka, A. K., Franklin, R. M., Adkinson, N. F., Valentine, M. D., Baer, H., & Lichtenstein, L. M. (1976) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(76)90076-2 · Cited by 144
Schleimer, R. P., Derse, C. P., Friedman, B., Gillis, S. A., Plaut, M., Lichtenstein, L. M., & MacGlashan, D. W. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1310 · Cited by 133
Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols
Birnbaum, J., Charpin, D., & VERVLOET, D. (1993) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1993.tb00886.x · Cited by 130
Changes in nasal metachromatic cells during allergen immunotherapy
Otsuka, H., Mezawa, A., Ohnishi, M., Okubo, K., Seki, H., & Okuda, M. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb00812.x · Cited by 101
Jutel, M., MULLER, U. R., ERICKER, M., Rihs, S., Pichler, W. J., & Dahinden, C. A. (1996) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1996.d01-259.x · Cited by 99
Maintenance of clonal anergy by endogenously produced IL-10
Becker, J. C., Czerny, C., & Bröcker, E. ‐. (1994) · International Immunology · doi:10.1093/intimm/6.10.1605 · Cited by 99
Zuany‐Amorim, C., Créminon, C., Nevers, M., Nahori, M., Vargaftig, B. B., & Pretolani, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.377 · Cited by 92
Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar
Müller, U., Dudler, T., Schneider, T., Crameri, R., Fischer, H., Skrbic, D., Maibach, R., Blaser, K., & Suter, M. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70059-5 · Cited by 91
Self-citationInterleukin‐10 inhibits cytokine generation from mast cells
Arock, M., Zuany‐Amorim, C., Singer, M., Benhamou, M., & Pretolani, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260126 · Cited by 89
Akdiş, C. A., Blesken, T., Akdis, M., Alkan, S. S., Wüthrich, B., Heusser, C. H., & Blaser, K. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70052-6 · Cited by 66
Self-citationAkdiş, C. A., Blesken, T., Akdiş, M., Alkan, Ş. Ş., Heusser, C., & Blaser, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270933 · Cited by 62
Self-citationCarballido, J. M., Carballido‐Perrig, N., OBERLISCHRAMMLI, A., Heusser, C. H., & Blaser, K. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90256-9 · Cited by 59
Self-citationEvaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy
RANDOLPH, C. C., & Reisman, R. E. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90379-9 · Cited by 58
Carballido, J. M., Faith, A., Carballido‐Perrig, N., & Blaser, K. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270224 · Cited by 58
Self-citationWyss, M., Scheitlin, T., Stadler, B. M., et al. (1993) · Allergy · doi:10.1111/j.1398-9995.1993.tb00690.x · Cited by 58
Igg subclass-restricted immune responses to allergens
Lucas, A. H. (1990) · Springer Seminars in Immunopathology · doi:10.1007/bf00225325 · Cited by 36
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Allergy, Parasites, and the Hygiene Hypothesis
Yazdanbakhsh, M., Kremsner, P. G., & van Ree, R. (2002) · Science · doi:10.1126/science.296.5567.490 · Cited by 1,526
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & O'Garra, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011629 · Cited by 1,161
Metadata
- Authors
- Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B., & Blaser, K.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-07-01
- Volume
- 102
- Issue
- 1
- Pages
- 98-106
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2075875408
- Cited by
- 973
- References
- 56
- FWCI
- 15.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.